Clinical Trial Update: An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Placement of an Arteriovenous Graft to Facilitate Hemodialysis Access [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SRM003 for patients undergoing placement of an arteriovenous graft for hemodialysis access; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Graft For Hemodialysis Access

Drugs mentioned

• SRM003

Snippet

Sponsor: Shire | Conditions: Arteriovenous Graft | Phase 2 | Status: TERMINATED | Results posted: 2015-12-31